Investing

BioCryst Pharmaceuticals : BCRX

BCRX

Stock Data

$9.84

$0.46 (4.90%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Biocryst Pharmaceuticals Inc is a biotechnology firm focused on developing treatments for rare diseases. It offers RAPIVAB, RAPIACTA, and PERAMIFLU, which are brands of peramivir injection for acute influenza, and ORLADEYO, an oral treatment for hereditary angioedema. The company is also working on BCX10013, targeting complement-mediated diseases. Founded in 1986 and based in Durham, North Carolina, Biocryst collaborates with various global institutions and companies to advance its research and development efforts.

All BioCryst Pharmaceuticals Articles

77 Articles

Trey Thoelcke | Oct 9, 2024 at 9:15 AM EDT

Prediction: This Will Be the Best-Performing Growth Stock Over the Next 5 Years

These five candidates to be the best-performing growth stock over the next five years include biotech, energy, and software stocks.

Lee Jackson | Sep 19, 2023 at 8:42 AM EDT

Tuesday’s Top Analyst Upgrades and Downgrades: Adobe, Carvana, DoorDash, Micron Technology, Netflix, Nike, PayPal and More

Tuesday's top analyst upgrades and downgrades included Adobe, Annaly Capital Management, BioCryst Pharmaceuticals, Carvana, DoorDash, Kimco Realty, Micron Technology, Netflix,…

Lee Jackson | Aug 7, 2023 at 8:54 AM EDT

Monday’s Top Wall Street Analyst Upgrades and Downgrades: Amazon, Apple, Block, Coinbase, Datadog, Fortinet, Gilead Sciences, Moderna, Nvidia, PayPal, Petrobras and More

Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental…

Lee Jackson | Feb 23, 2023 at 8:53 AM EST

Thursday’s Top Analyst Upgrades and Downgrades: AIG, Alcoa, Coinbase, Home Depot, Merck, Nvidia, Palo Alto Networks, Occidental Petroleum, Salesforce, Shopify, Sirius XM, Target and More

Thursday's top analyst upgrades and downgrades included Alcoa, American International Group, BioCryst Pharmaceuticals, Coinbase Global, GitLab, Home Depot, Merck, Nvidia,…

Lee Jackson | Nov 3, 2022 at 8:53 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton, Snowflake, SoFi and More

Thursday's top analyst upgrades and downgrades included BioCryst Pharmaceutical, Canopy Growth, Cleveland-Cliffs, Datadog, Electronic Arts, Palo Alto Networks, Peloton Interactive,…

Chris Lange | Aug 5, 2022 at 10:40 AM EDT

Huge July Employment Report: Analysts Upgrade or Downgrade Duke Energy, Paramount, Teva Pharmaceutical and More

Friday's additional top analyst upgrades and downgrades included Acadia Pharmaceuticals, BioCryst Pharmaceuticals, Duke Energy, Kellogg, Paramount Global, Rhythm Pharmaceuticals and…

Lee Jackson | May 13, 2022 at 8:56 AM EDT

Friday’s Top Analyst Upgrades Downgrades: Boeing, Disney, Gilead Sciences, IBM, Rivian, Roblox, Visa and More

Friday's top analyst upgrades and downgrades included AppLovin, BioCryst Pharmaceuticals, Boeing, CF Industries, Coupa Software, Crocs, Dutch Bros, DigitalOcean, Gilead…

Chris Lange | Apr 18, 2022 at 11:22 AM EDT

Is Earnings Optimism Enough? Analyst Upgrades and Downgrades: CSX, Gap, Peloton, United Airlines and More

Monday’s additional top analyst upgrades and downgrades included Aptiv, BioCryst Pharmaceuticals, CSX, Gap, Nektar Therapeutics, Progressive, Peloton Interactive, Sirius XM…

Chris Lange | Apr 11, 2022 at 8:56 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Alibaba, AT&T, JetBlue, Nvidia, Pinduoduo, Schlumberger, US Bancorp, Wells Fargo and More

Monday's top analyst upgrades and downgrades included Alibaba, AT&T, Baidu, Bilbili, CommScope, JetBlue Airways, Navient, Nvidia, Pinduoduo, Schlumberger, Sea, State…

Chris Lange | Aug 3, 2021 at 12:36 PM EDT

Tuesday Afternoon Analyst Upgrades and Downgrades: Exxon Mobil, First Solar, Tesla and More

24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Tuesday, including…

Chris Lange | Mar 1, 2021 at 12:01 PM EST

BioCryst, Editas, Groupon, Sunrun, Twitter and More of Monday Afternoon’s Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including BioCryst, Editas,…

Lee Jackson | Jun 13, 2020 at 6:15 AM EDT

BofA Securities Has 5 Stocks to Buy Under $10 With Massive Upside Potential

Ford, General Electric and these other stocks are likely to survive the current troubles and could very well offer patient…

Jon C. Ogg | May 5, 2020 at 8:58 AM EDT

Top Analyst Upgrades and Downgrades: AppFolio, BioCryst, Booking, DraftKings, Intuit, L Brands, Peloton, Salesforce, Wells Fargo and More

Tuesday's top analyst upgrades and downgrades included AppFolio, BioCryst Pharmaceuticals, Booking, DraftKings, Intuit, L Brands, Peloton Interactive, Salesforce.com and Wells…

Chris Lange | Jan 27, 2020 at 10:05 AM EST

12 Stocks Surging That Could Help Treat or Fight Coronavirus

As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares…

Jon C. Ogg | Jan 26, 2020 at 11:25 AM EST

As Coronavirus Spreads, Sensitive China, US, Global Economies Face Great Risks

The Wuhan Coronavirus has escaped China, with the number of cases and the death toll rising. The economic impact beyond…